Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Leptomeningeal contrast enhancement (LMCE) on magnetic resonance imaging (MRI) is a newly recognized possible biomarker in multiple sclerosis (MS), associated with MS progression and cortical atrophy. In this study, we aimed to assess the prevalence of LMCE foci and their impact on neurodegeneration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Res Int
Main Authors: Makshakov, Gleb, Magonov, Evgeniy, Totolyan, Natalia, Nazarov, Vladimir, Lapin, Sergey, Mazing, Alexandra, Verbitskaya, Elena, Trofimova, Tatiana, Krasnov, Vladimir, Shumilina, Maria, Skoromets, Alexander, Evdoshenko, Evgeniy
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643086/
https://ncbi.nlm.nih.gov/pubmed/29291134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8652463
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados